EUR/USD Signal Today 06/02: Rallies To 50 Day EMA (Chart)
Potential signal: <li /> I am a seller of this pair, right here, right now. <li /> I would have a stop loss at 1.0510 and would be aiming for a ...
GBP/JPY Price Forecast: Bearish outlook remains intact below 190.50
The Japanese Yen (JPY) is one of the world’s most traded currencies. Its value is broadly determined by the performance of the Japanese economy, but more specifically by the Bank of Japan’s policy, ...
centerforbiosimilars5h
CHMP Pushes 3 Biosimilars Forward, Spelling Hope for Ophthalmology, Supportive Care Markets
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar
Greg Siokas, CEO of Cosmos Health, stated: 'We are delighted to announce our first order from Al Rabwa, allowing us to capitalize on Qatar's rapidly expanding market. This is another important ...
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...
Life Science Leader8h
The Spark Of Change In Healthcare's 2024 Investment Ecosystem
Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...